This is an investigational study. Atezolizumab is FDA approved and commercially available for the treatment of non-small cell lung cancer and bladder cancer. Cobimetinib is FDA approved and commercially available for the treatment of certain types of melanoma. It is investigational to give these drugs in combination to patients with thyroid cancer.